Literature DB >> 8611416

Familial testicular cancer in Norway and southern Sweden.

K Heimdal1, H Olsson, S Tretli, P Flodgren, A L Børresen, S D Fossa.   

Abstract

Information about occurrence of testicular cancer (TC) in relatives of TC patients has been collected using questionnaires from 797 out of 922 consecutive Norwegian and 178 out of 237 Swedish patients with TC seen at the Norwegian Radium Hospital and the University Hospital Lund in Sweden during 1981-91. Fifty-one Norwegian and five Swedish patients had a relative with confirmed TC. Thus, 51/922 (5.5%) of the Norwegian and 5/237 (2.1%) of the Swedish patients treated during the time interval investigated were considered to have familial TC. Thirty-two of the patients had an affected first-degree relative. Expected numbers of cancers in the relatives were computed from data in the Norwegian and Swedish Cancer Registries. Standardised incidence ratios (SIRs) were taken as observed numbers of TC/expected numbers of TC in the relatives. The SIR for brothers was 10.2 (95% confidence interval 6.22-15.77). SIR for fathers was 4.3 (1.6-9.3) and for sons 5.7 (0.7-23.2). The point estimate for the risk to brothers in the Norwegian part of the sample to develop TC by the age of 60 was 4.1% (95% CI 1.7-6.6%). This study indicates that genetic factors may be of greater importance in TC than previously assumed. Patients with familial testicular cancer had bilateral tumours more often than sporadic cases (9.8% bilaterality in familial vs 2.8% in sporadic cases, P=0.02). For patients with seminoma age of onset was lower in familial than in sporadic cases (32.9 vs 37.6 years, P=0.06). In father-son pairs, there was a statistically significant earlier age of diagnosis in the generation of sons (28.8 years vs 44.9 years, P=0.04). The prevalence of undescended testis (UDT) did not seem to be higher in familial than in sporadic TC (8.2% in familial TC and 13.3% in sporadic cases). This may indicate that different factors are of importance for the development of familial TC and UDT.

Entities:  

Mesh:

Year:  1996        PMID: 8611416      PMCID: PMC2074255          DOI: 10.1038/bjc.1996.173

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  7 in total

1.  Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia.

Authors:  A L Børresen; T I Andersen; S Tretli; A Heiberg; P Møller
Journal:  Genes Chromosomes Cancer       Date:  1990-11       Impact factor: 5.006

2.  Can familial aggregation of disease be explained by familial aggregation of environmental risk factors?

Authors:  M J Khoury; T H Beaty; K Y Liang
Journal:  Am J Epidemiol       Date:  1988-03       Impact factor: 4.897

Review 3.  Inheritance and testicular cancer. Arguments based on a report of 3 cases and a review of the literature.

Authors:  K P Dieckmann; T Becker; D Jonas; H W Bauer
Journal:  Oncology       Date:  1987       Impact factor: 2.935

4.  Father-son testicular malignancy. Does genetic anticipation occur?

Authors:  D Raghavan; T Jelihovsky; R M Fox
Journal:  Cancer       Date:  1980-03-01       Impact factor: 6.860

5.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

6.  Familial testicular cancer and urogenital developmental anomalies.

Authors:  D J Tollerud; W A Blattner; M C Fraser; L M Brown; L Pottern; E Shapiro; A Kirkemo; T H Shawker; N Javadpour; K O'Connell
Journal:  Cancer       Date:  1985-04-15       Impact factor: 6.860

7.  Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis.

Authors:  D Forman; R T Oliver; A R Brett; S G Marsh; J H Moses; J G Bodmer; C E Chilvers; M C Pike
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

  7 in total
  46 in total

Review 1.  Clinical epidemiology of testicular germ cell tumors.

Authors:  K-P Dieckmann; U Pichlmeier
Journal:  World J Urol       Date:  2004-03-18       Impact factor: 4.226

2.  X-linked tumor suppressors: perplexing inheritance, a unique therapeutic opportunity.

Authors:  Yang Liu; Lizhong Wang; Pan Zheng
Journal:  Trends Genet       Date:  2010-04-29       Impact factor: 11.639

3.  Testicular germ cell tumor susceptibility genes from the consomic 129.MOLF-Chr19 mouse strain.

Authors:  Rui Zhu; Yuan Ji; Lianchun Xiao; Angabin Matin
Journal:  Mamm Genome       Date:  2007-08-02       Impact factor: 2.957

4.  Increased predisposition to cancer in brothers and offspring of testicular tumor patients.

Authors:  Sarolta Gundy; Mária Babosa; Márta Baki; István Bodrogi
Journal:  Pathol Oncol Res       Date:  2004-12-27       Impact factor: 3.201

5.  Constitutional cytogenetic analysis in men with hereditary testicular germ cell tumor: no evidence of disease-related abnormalities.

Authors:  Christine M Mueller; Larissa Korde; Hormuzd A Katki; Philip S Rosenberg; June A Peters; Mark H Greene
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-12       Impact factor: 4.254

Review 6.  Testicular germ cell tumours: predisposition genes and the male germ cell niche.

Authors:  Duncan Gilbert; Elizabeth Rapley; Janet Shipley
Journal:  Nat Rev Cancer       Date:  2011-03-17       Impact factor: 60.716

7.  Future of testicular germ cell tumor incidence in the United States: Forecast through 2026.

Authors:  Armen A Ghazarian; Scott P Kelly; Sean F Altekruse; Philip S Rosenberg; Katherine A McGlynn
Journal:  Cancer       Date:  2017-02-27       Impact factor: 6.860

Review 8.  Etiologic factors in testicular germ-cell tumors.

Authors:  Katherine A McGlynn; Michael B Cook
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

9.  The role of the mouse y chromosome on susceptibility to testicular germ cell tumors.

Authors:  Philip D Anderson; Man-Yee Lam; Christophe Poirier; Colin E Bishop; Joseph H Nadeau
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

10.  Clinical and genetic aspects of testicular germ cell tumours.

Authors:  Martijn F Lutke Holzik; Rolf H Sijmons; Josette Ehm Hoekstra-Weebers; Dirk T Sleijfer; Harald J Hoekstra
Journal:  Hered Cancer Clin Pract       Date:  2008-02-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.